miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment.

Anajafi, Sara; Paryan, Mahdi; Khoshnazar, Amineh; Soleimani, Masoud; Mohammadi-Yeganeh, Samira

Anajafi, Sara; Paryan, Mahdi; Khoshnazar, Amineh; Soleimani, Masoud; Mohammadi-Yeganeh, Samira.

Afiliação

Anajafi S; Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Paryan M; Department of Research and Development, Production and Research Complex, Pasteur Institute of Iran, Tehran, Iran.
Khoshnazar A; Shahid Beheshti University of Medical Sciences Medical Biotechnology Tehran Iran.
Soleimani M; Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammadi-Yeganeh S; Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Endocr Metab Immune Disord Drug Targets ; 2023 Aug 23.

Article em En | MEDLINE | ID: mdl-37612874

Palavras-chave

Cancer-Associated Fibroblast (CAF); Drug delivery; Drug resistance; Signaling pathways; Tumor microenvironment; miRNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Endocr Metab Immune Disord Drug Targets Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google